Does haste make waste? Prevalence and types of errors reported after publication of studies of COVID-19 therapeutics

Wilkes MS. Medical researchers and the media: attitudes toward public dissemination of research. JAMA. 1992;268(8):999. https://doi.org/10.1001/jama.1992.03490080073027.

Article  CAS  PubMed  Google Scholar 

Hauptman PJ, Armbrecht ES, Chibnall JT, Guild C, Timm JP, Rich MW. Errata in medical publications. Am J Med. 2014;127(8):779-785.e1. https://doi.org/10.1016/j.amjmed.2014.03.012.

Article  PubMed  Google Scholar 

Isaacson W. The Code Breaker: Jennifer Doudna, Gene Editing, and the Future of the Human Race. Simon & Schuster. 2021.

Google Scholar 

Putman MS, Ruderman EM, Niforatos JD. Publication rate and journal review time of COVID-19–related research. Mayo Clin Proc. 2020;95(10). https://doi.org/10.1016/j.mayocp.2020.08.017.

Boschiero MN, Carvalho TA, Marson FA de L. Retraction in the era of COVID-19 and its influence on evidence-based medicine: is science in jeopardy? Pulmonology. 2021;27(2):97–106. https://doi.org/10.1016/j.pulmoe.2020.10.011.

Article  PubMed  Google Scholar 

Frampton G, Woods L, Scott DA. Inconsistent and incomplete retraction of published research: a cross-sectional study on COVID-19 retractions and recommendations to mitigate risks for research, policy and practice. Ochodo E, ed. PLoS One. 2021;16(10):e0258935. https://doi.org/10.1371/journal.pone.0258935.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Soltani P, Patini R. Retracted COVID-19 articles: a side-effect of the hot race to publication. Scientometrics. 2020;125(1):819–22. https://doi.org/10.1007/s11192-020-03661-9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shi X, Abritis A, Patel RP, et al. Characteristics of retracted research articles about COVID-19 vs other topics. JAMA Netw Open. 2022;5(10):e2234585. https://doi.org/10.1001/jamanetworkopen.2022.34585.

Article  PubMed  PubMed Central  Google Scholar 

Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2). https://doi.org/10.1016/j.jbi.2008.08.010.

Ravichandran R, Mohan SK, Sukumaran SK, et al. An open label randomized clinical trial of Indomethacin for mild and moderate hospitalised COVID-19 patients. Sci Rep. 2022;12(1):6413. https://doi.org/10.1038/s41598-022-10370-1.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Blum VF, Cimerman S, Hunter JR, et al. Nitazoxanide superiority to placebo to treat moderate COVID-19 – a pilot prove of concept randomized double-blind clinical trial. eClinicalMedicine. 2021;37:100981. https://doi.org/10.1016/j.eclinm.2021.100981.

Article  PubMed  PubMed Central  Google Scholar 

Liu JY, Hua MX, Du CJ, et al. The dual role of anti-viral therapy in the treatment of coronavirus disease 2019. Eur Rev Med Pharmacol Sci. 2020;24(22). https://doi.org/10.26355/eurrev_202011_23854.

Gharebaghi N, Nejadrahim R, Mousavi SJ, Sadat-Ebrahimi SR, Hajizadeh R. The use of intravenous immunoglobulin gamma for the treatment of severe coronavirus disease 2019: a randomized placebo-controlled double-blind clinical trial. BMC Infect Dis. 2020;20(1). https://doi.org/10.1186/s12879-020-05507-4.

Agarwal A, Mukherjee A, Kumar G, Chatterjee P, Bhatnagar T, Malhotra P. Convalescent plasma in the management of moderate COVID-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial). BMJ. 2020;371. https://doi.org/10.1136/bmj.m3939.

Hermine O, Mariette X, Tharaux PL, Resche-Rigon M, Porcher R, Ravaud P. Effect of tocilizumab vs usual care in adults hospitalized with COVID-19 and moderate or severe pneumonia: a randomized clinical trial. JAMA Intern Med. 2021;181(1). https://doi.org/10.1001/jamainternmed.2020.6820.

Guan WJ, Wei CH, Chen AL, et al. Hydrogen/oxygen mixed gas inhalation improves disease severity and dyspnea in patients with coronavirus disease 2019 in a recent multicenter, open-label clinical trial. J Thorac Dis. 2020;12(6). https://doi.org/10.21037/jtd-2020-057.

Seo H, Kim H, Bae S, et al. Fluvoxamine treatment of patients with symptomatic COVID-19 in a community treatment center: a preliminary result of randomized controlled trial. Infect Chemother. 2022;54(1):102. https://doi.org/10.3947/ic.2021.0142.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bégin P, Callum J, Jamula E, et al. Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial. Nat Med. 2021;27(11):2012–24. https://doi.org/10.1038/s41591-021-01488-2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hu K, Guan W, Bi Y, et al. Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: a multicenter, prospective, randomized controlled trial. Phytomedicine. 2021;85:153242. https://doi.org/10.1016/j.phymed.2020.153242.

Article  CAS  PubMed  Google Scholar 

Kyriazopoulou E, Poulakou G, Milionis H, et al. Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial. Nat Med. 2021;27(10):1752–60. https://doi.org/10.1038/s41591-021-01499-z.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Krolewiecki A, Lifschitz A, Moragas M, et al. Antiviral effect of high-dose ivermectin in adults with COVID-19: a proof-of-concept randomized trial. eClinicalMedicine. 2021;37:100959. https://doi.org/10.1016/j.eclinm.2021.100959.

Article  PubMed  PubMed Central  Google Scholar 

Sharma A, Shah M, Lakshmi S, et al. A pilot study for treatment of COVID-19 patients in moderate stage using intravenous administration of ozonized saline as an adjuvant treatment-registered clinical trial. Int Immunopharmacol. 2021;96:107743. https://doi.org/10.1016/j.intimp.2021.107743.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pandit A, Bhalani N, Bhushan BLS, et al. Efficacy and safety of pegylated interferon alfa-2b in moderate COVID-19: a phase II, randomized, controlled, open-label study. Int J Infect Dis. 2021;105:516–21. https://doi.org/10.1016/j.ijid.2021.03.015.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liesenborghs L, Spriet I, Jochmans D, et al. Itraconazole for COVID-19: preclinical studies and a proof-of-concept randomized clinical trial. EBioMedicine. 2021;66:103288. https://doi.org/10.1016/j.ebiom.2021.103288.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ribeiro TB, Mazotti TA, Silva NA de O, Stein AT, Diaz-Quijano FA, de Melo DO. Evaluation of the initial response in clinical trial efforts for COVID-19 in brazil. Rev Bras Epidemiol. 2020;23:1–13. https://doi.org/10.1590/1980-549720200104.

Article  Google Scholar 

Axfors C, Schmitt AM, Janiaud P, et al. Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials. Nat Commun. 2021;12(1). https://doi.org/10.1038/s41467-021-22446-z.

Rojas-Marte G, Khalid M, Mukhtar O, et al. Outcomes in patients with severe COVID-19 disease treated with tocilizumab: a case-controlled study. QJM. 2020;113(8). https://doi.org/10.1093/qjmed/hcaa206.

Royle P, Waugh N. Should systematic reviews include searches for published errata? Heal Inf Libr J. 2004;21(1):14–20. https://doi.org/10.1111/j.1471-1842.2004.00459.x.

Article  Google Scholar 

Farrah K, Rabb D. Errata for trial publications are not uncommon, are frequently not trivial, and can be challenging to access: a retrospective review. J Med Libr Assoc. 2019;107(2). https://doi.org/10.5195/jmla.2019.629.

Molckovsky A, Vickers MM, Tang P. Characterization of published errors in high-impact oncology journals. Curr Oncol. 2011;18(1):26–32. https://doi.org/10.3747/co.v18i1.707.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Castillo M, Northam M, Halm KE. Postpublication errors in imaging-related journals. Am J Neuroradiol. 2012;33(8):1447–8. https://doi.org/10.3174/ajnr.A3026.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Trikalinos TA. Does it mean anything if your own name is wrong in your published paper? FASEB J. 2009;23(8):2345–8. https://doi.org/10.1096/fj.09-130922.

Article  CAS  PubMed  Google Scholar 

Bhatt VR, Aryal MR, Panta S, Mosalpuria K, Armitage JO. A retrospective analysis of reported errata in five leading medical journals in 2012. J Community Hosp Intern Med Perspect. 2014;4(5):25738. https://doi.org/10.3402/jchimp.v4.25738.

Article  PubMed  Google Scholar 

Peterson CJ, Alexander R, Nugent K. COVID-19 article retractions in journals indexed in PubMed. Am J Med Sci. 2022;364(1). https://doi.org/10.1016/j.amjms.2022.01.014.

留言 (0)

沒有登入
gif